Science World Report In a collaborative effort, researchers from St. Olavs Hospital in Trondheim, Norway and the Norwegian University of Science and Technology (NTNU) ha...
Drug Discovery & Development Takeda Pharmaceutical Co. Ltd. received notice of sanctions imposed by the Japan Pharmaceutical Manufacturers Association (JPMA) for promotional activities regarding Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J). The sanctions ...
Medscape BOSTON — The angiotensin receptor blocker candesartan (Atacand, AstraZeneca Pharmaceuticals LP) is safe and as effective as the beta blocker propranolol in preventing migraine headaches, according to a new study. The results of the randomized, ...
iStockAnalyst (press release) For instance, Candesartan , the product we launched last November, is sold at a price that supports our gross margin. Our selling expenses for the three months ended September 30, 2014 were $0.7 million, compared to $0.9 million in the same period last ... and more »
Toronto Star Health Canada said at the time that the company refused. The Star has also learned from new FDA records that Apotex recently recalled more than 60,000 bottles of blood pressure tablets — a medication called candesartan cilexetil — because of impurities. and more »
FiercePharma Manufacturing According to four notices in the most recent FDA Enforcement Report, Apotex is recalling 65,442 bottles of candesartan cilexetil made at the company's plant in Bangalore after testing found they contained excessive levels of impurities. The FDA banned ...
Business Wire (press release) Global Market Report of Candesartan cilexetil (CAS 145040-37-5) aims at providing comprehensive data on Candesartan cilexetil globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Candesartan cilexetil market trends ... and more »
Medscape However, in CHARM-Added, candesartan decreased the combined end point (cardiovascular death and hospital readmission for CHF) even in the subpopulation that was already receiving an ACE inhibitor and beta-blocker. Meanwhile, the prevalence of ...
